| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 45.654 | 19.155 | 3.515 | 414.974 | 504.480 | 419.556 | 209.066 |
| Total Income - EUR | - | - | 0 | 45.654 | 19.157 | 3.527 | 415.003 | 508.514 | 423.828 | 211.478 |
| Total Expenses - EUR | - | - | 1.538 | 24.031 | 28.023 | 31.429 | 178.501 | 229.055 | 233.028 | 124.798 |
| Gross Profit/Loss - EUR | - | - | -1.538 | 21.623 | -8.866 | -27.902 | 236.502 | 279.459 | 190.800 | 86.679 |
| Net Profit/Loss - EUR | - | - | -1.538 | 20.869 | -9.041 | -27.938 | 234.000 | 275.477 | 187.918 | 74.201 |
| Employees | - | - | 0 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Medisprof Radioterapie Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 1.488 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 32 | 38.375 | 41.072 | 2.467 | 233.037 | 715.841 | 666.391 | 757.479 |
| Inventories | - | - | 0 | 0 | 6.771 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 37.015 | 30.440 | 1.574 | 119.343 | 469.650 | 611.756 | 650.320 |
| Cash | - | - | 32 | 1.359 | 3.861 | 893 | 113.693 | 246.191 | 54.634 | 107.159 |
| Shareholders Funds | - | - | -1.494 | 19.402 | 9.985 | -18.142 | 216.260 | 275.525 | 254.289 | 74.249 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 1.526 | 18.972 | 32.574 | 20.609 | 16.777 | 440.315 | 412.101 | 683.231 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medisprof Radioterapie Srl